User Reviews for Oxymetazoline

Also known as: OcuClear, Visine L.R., Visine Long Lasting

The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.

Filter by:

Learn more about Oxymetazoline.

Condition	Reviews	Compare	Avg. Ratings
Eye Dryness/Redness	0 reviews	192 medications	Not rated - Be the first
Eye Redness/Itching	0 reviews	76 medications	Not rated - Be the first

Reviews for Oxymetazoline

There are no reviews - Be the first

Related Oxymetazoline ophthalmic Information

Availability Over the counter

CSA Schedule Not a controlled drug

Pregnancy Category Risk cannot be ruled out

Approval History Drug history at FDA

FDA Consumer Updates

More FDA Updates...

Related Pages

Drug Class

Ophthalmic antihistamines and decongestants

Recently Approved

Mitosol
Mitosol (mitomycin) is an antimetabolite indicated as an adjunct to ab externo glaucoma surgery.
Sklice
Sklice (ivermectin) Lotion is a pediculicide indicated for the topical treatment of head lice infestations in ...
Jentadueto
Jentadueto (linagliptin and metformin) is a dipeptidyl peptidase-4 (DPP-4) inhibitor and biguanide ...
Kalydeco
Kalydeco (ivacaftor) is a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator indicated ...
Erivedge
Erivedge (vismodegib) is a hedgehog pathway inhibitor for the treatment of patients with advanced basal cell ...

More...

Get Updates by Email

Email me about oxymetazoline ophthalmic:

Related News and Articles

RegeneRx Receives Clinical Study Report for Phase 2 Dry Eye Trial 5 January 2012
Jan 5, 2012 - RegeneRx Biopharmaceuticals, Inc. (OTC Bulletin Board: RGRX) (“the Company” or “RegeneRx”) announced today that it has received the...
RegeneRx Answers Questions Regarding Phase 2 Dry Eye Trial 4 November 2011
Nov 4, 2011 - RegeneRx Biopharmaceuticals, Inc. (OTC Bulletin Board: RGRX) (“the Company” or “RegeneRx”). In response to questions received related...
RegeneRx Reports Positive Data with RGN-259 in Phase 2 Dry Eye Trial 4 November 2011
First-in-class molecule reduces specific signs & symptoms in placebo-controlled challenge study ROCKVILLE, Md.--(BUSINESS WIRE)--Nov 4, 2011 -...
RegeneRx Reports New Statistically Significant Data Confirming Repair of Corneal Damage in Dry Eye Model 13 April 2011
Apr 13, 2011 - RegeneRx Biopharmaceuticals, Inc. (OTC Bulletin Board: RGRX) (“the Company” or “RegeneRx”) today announced positive new data related...
SARcode Corporation to Present Phase 2 Clinical Data for Dry Eye Candidate at the ARVO2011 Annual Meeting 24 March 2011
SARcode Corporation announced today that clinical data for their lead compound, SAR 1118, has been accepted for presentation during the upcoming Association...

Help and Support

Looking for answers? Ask a question or go join the oxymetazoline support group to connect with others who have similar interests.

Did you find this page helpful? Yes No

Support

About Drugs.com

Your Privacy

Follow us on: Google+ Facebook Twitter

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines & natural products. This material is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.

Data sources include Micromedex™ (updated Jan 27th, 2011), Cerner Multum™ (updated Jan 3rd, 2012), Wolters Kluwer™ (updated Jan 31st, 2012) and others.
To view content sources and attributions, refer to our editorial policy.

We comply with the HONcode standard for trustworthy health information.
Verify here

Terms of Use · Privacy Policy

Browse all medications A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Advanced Phonetic
Search:

User Reviews for Oxymetazoline

Reviews for Oxymetazoline

See also...

Related Oxymetazoline ophthalmic Information